New Insights into Glioblastoma: Cell Clustering May Influence Tumor Aggressiveness

New research uncovers how glioblastoma cell clustering influences tumor severity. Dispersed cells show higher plasticity and treatment resistance, offering potential new therapeutic targets.
Recent research from the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has uncovered new details about glioblastoma, one of the most aggressive brain tumors. Using advanced spatial transcriptomics technology, scientists observed that glioblastoma cells tend to form clusters of the same cell type and that these clustered cells are less aggressive compared to dispersed cells that break away from these groups. Interestingly, the dispersed tumor cells exhibit higher plasticity, meaning they can easily change their properties, which is associated with increased treatment resistance and poorer patient outcomes.
The study revealed that tumor cells in clusters express surface proteins that help them stick together, while dispersed cells lack these adhesion molecules, making them more mobile and adaptable. These findings were also confirmed in breast cancer samples, suggesting that the principles governing tumor cell behavior might be applicable across various solid cancers.
The researchers hypothesize that current treatments like chemotherapy and radiation might inadvertently cause tumor cells to disperse by disrupting their clusters, thereby increasing their plasticity and harmfulness. Understanding the mechanisms behind cell clustering and dispersal could open new pathways for therapy, aiming to promote cluster formation or inhibit cell dispersal to reduce tumor aggressiveness.
Led by Dr. Anna Lasorella and Dr. Antonio Iavarone, the team’s work provides a deeper understanding of the biology of glioblastoma and offers hope for developing strategies to limit tumor progression by controlling cell adhesion and plasticity. Their findings emphasize the potential of targeting tumor cell organization to improve treatment outcomes for patients with this deadly cancer.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Metabolic Syndrome Elevates Risk of Developing Parkinson's Disease
New research reveals that metabolic syndrome significantly increases the risk of developing Parkinson's disease, emphasizing the importance of metabolic health in neurological well-being.
FDA Restricts Access to Updated COVID-19 Vaccines, Bringing New Challenges for Children's Immunization
The FDA's recent approval of updated COVID-19 vaccines introduces new restrictions that could limit vaccine access for healthy children, raising concerns among parents and health professionals about protecting vulnerable populations amidst ongoing policy shifts.
Innovative Non-Opioid Strategies for Pain Management Developed by Researchers
Researchers at the University of Texas at San Antonio are developing innovative non-opioid treatments for pain management, focusing on molecular targets to reduce addiction risks and improve patient outcomes.



